Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

87
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
87
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

289
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

387
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
387
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

228
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
228

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

MAPK signaling pathway and rhizosphere modulation: mechanisms of arbuscular mycorrhizal symbiosis in enhancing Phragmites communis tolerance to triclocarban stress.

Mycorrhiza·2026
Same author

Aqueous PFOS exposure decouples gaseous carbon loss from mineral-associated carbon retention in controlled wetland-interface mesocosms.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Giant surface potentials in organic films enable electrode-free self-driven water droplets.

Materials horizons·2026
Same author

Discussion on ''Nonparanormal Adjusted Marginal Inference'' by Susanne Dandl and Torsten Hothorn.

Biometrics·2026
Same author

A digital twin methodology using retrospective patient data for sample size reduction in Alzheimer's disease clinical trials.

Alzheimer's research & therapy·2026
Same author

It's about time: The association between abacavir and cardiovascular disease.

Antiviral therapy·2026

相关实验视频

Updated: Sep 14, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

706

对个性化治疗的稀疏的2阶段贝叶斯元分析.

Junwei Shen1, Erica E M Moodie1, Shirin Golchi1

  • 1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec H3A 1G1, Canada.

Biometrics
|July 24, 2025
PubMed
概括
此摘要是机器生成的。

这项研究引入了贝叶斯的元分析,用于个性化治疗规则,使用多个站点的数据,而无需共享患者级信息. 该方法有效地确定了最佳的治疗策略,由华法林剂量证明.

关键词:
贝叶斯元分析贝叶斯元分析个性化待遇规则 个人化待遇规则多站点研究多站点研究个性化医疗是个性化的医疗.

更多相关视频

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.5K

相关实验视频

Last Updated: Sep 14, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

706
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.5K

科学领域:

  • 生物统计学 生物统计学
  • 药物遗传学 药物遗传学
  • 临床试验设计 临床试验设计

背景情况:

  • 个性化治疗规则 (ITR) 通过根据特征量身定制治疗来优化患者护理.
  • 估计ITR需要检测治疗效果的变化,通常需要大型的多站点数据集.
  • 多站点数据分析面临诸如数据共享约束和统计稀疏等挑战.

研究的目的:

  • 开发一种可靠的方法,使用多站点数据估计ITR,同时保持数据隐私.
  • 为了解决数据稀疏性和多站点研究中常见的小治疗-共变相互作用.
  • 通过数据驱动的个性化治疗策略,优化患者的治疗结果.

主要方法:

  • 采用了两阶段的贝叶斯元分析方法.
  • 该方法使用多站点数据估计ITR,而不披露个人级别数据.
  • 该方法旨在处理数据稀疏性并确定治疗效果的变化.

主要成果:

  • 模拟研究证实该方法为最佳ITR参数提供了一致的估计.
  • 该方法使用现实世界药物遗传学数据成功估计了华法林的最佳剂量策略.
  • 贝叶斯元分析有效地应对了数据稀疏性和小相互作用效应的挑战.

结论:

  • 提出的贝叶斯元分析是从多站点数据中估计ITR的强大工具.
  • 这种方法通过优化治疗策略而促进个性化医疗,而不会影响数据隐私.
  • 该方法为复杂的药物遗传学研究提供了可行的解决方案,数据稀少.